These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12366713)

  • 1. Fatal reactivation of hepatitis B virus following cytotoxic chemotherapy for acute myelogenous leukemia: fibrosing cholestatic hepatitis.
    Kojima H; Abei M; Takei N; Mukai Y; Hasegawa Y; Iijima T; Nagasawa T
    Eur J Haematol; 2002 Aug; 69(2):101-4. PubMed ID: 12366713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylaxis against chemotherapy-induced reactivation of hepatitis B virus infection with Lamivudine.
    Simpson ND; Simpson PW; Ahmed AM; Nguyen MH; Garcia G; Keeffe EB; Ahmed A
    J Clin Gastroenterol; 2003 Jul; 37(1):68-71. PubMed ID: 12811213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Four cases of hepatitis B virus-related fibrosing cholestatic hepatitis treated with lamivudine.
    Jung S; Lee HC; Han JM; Lee YJ; Chung YH; Lee YS; Kwon Y; Yu E; Suh DJ
    J Gastroenterol Hepatol; 2002 Mar; 17(3):345-50. PubMed ID: 11982709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hepatic toxicity during cyclic chemotherapy in non Hodgkin's lymphoma.
    Faggioli P; De Paschale M; Tocci A; Luoni M; Fava S; De Paoli A; Tosi A; Cassi E
    Haematologica; 1997; 82(1):38-42. PubMed ID: 9107080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
    Shtalrid M; Haran M; Klepfish A; Lurie Y; Malnick S
    Harefuah; 2001 Dec; 140(12):1159-62, 1230, 1229. PubMed ID: 11789300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical and histological features of fibrosing cholestatic hepatitis].
    Zhu Y; Luo K; Yu L
    Zhonghua Gan Zang Bing Za Zhi; 2002 Dec; 10(6):434-6. PubMed ID: 12502446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrosing cholestatic hepatitis-like syndrome in hepatitis B virus-negative and hepatitis C virus-negative renal transplant recipients.
    Muñoz de Bustillo E; Benito A; Colina F; Andrés A; Domínguez-Gil B; Muñoz MA; Rodicio JL; Morales JM
    Am J Kidney Dis; 2001 Sep; 38(3):640-5. PubMed ID: 11532698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lamivudine therapy in acute leukemia patients who are hepatitis B surface antigen carriers.
    Yilmaz M; Dagdas S; Güler N; Aki SZ; Aköz AG; Özet G; Ayli M; Saritas U
    Hematology; 2003 Dec; 8(6):393-6. PubMed ID: 14668034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis B virus reactivation in patients undergoing cytotoxic chemotherapy for solid tumours: precore/core mutations may play an important role.
    Steinberg JL; Yeo W; Zhong S; Chan JY; Tam JS; Chan PK; Leung NW; Johnson PJ
    J Med Virol; 2000 Mar; 60(3):249-55. PubMed ID: 10630955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant hepatitis type B after chemotherapy in a serologically negative hepatitis B virus carrier with acute myelogenous leukemia.
    Ishiga K; Kawatani T; Suou T; Tajima F; Omura H; Idobe Y; Kawasaki H
    Int J Hematol; 2001 Jan; 73(1):115-8. PubMed ID: 11372746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fibrosing cholestatic hepatitis--disease not only of transplanted patients. A report of eight cases].
    Honsová E; Sperl J
    Cesk Patol; 2011 Apr; 47(2):55-8. PubMed ID: 21604436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HbsAg carriers with lymphoid malignancies treated with chemotherapy.
    Rossi G; Pelizzari A; Motta M; Puoti M
    Br J Haematol; 2001 Oct; 115(1):58-62. PubMed ID: 11722410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
    Leaw SJ; Yen CJ; Huang WT; Chen TY; Su WC; Tsao CJ
    Ann Hematol; 2004 May; 83(5):270-5. PubMed ID: 15060745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
    Long M; Jia W; Li S; Jin L; Wu J; Rao N; Feng H; Chen K; Deng H; Liu F; Su F; Song E
    Breast Cancer Res Treat; 2011 Jun; 127(3):705-12. PubMed ID: 21445574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatal reactivation of hepatitis B virus in a patient who was hepatitis B surface antigen negative and core antibody positive before receiving chemotherapy for non-Hodgkin lymphoma.
    Wu JM; Huang YH; Lee PC; Lin HC; Lee SD
    J Clin Gastroenterol; 2009; 43(5):496-8. PubMed ID: 19247200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration of the dismal natural history of fibrosing cholestatic hepatitis secondary to hepatitis B virus with the use of lamivudine.
    Al Faraidy K; Yoshida EM; Davis JE; Vartanian RK; Anderson FH; Steinbrecher UP
    Transplantation; 1997 Sep; 64(6):926-8. PubMed ID: 9326423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report.
    Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K
    Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of hepatitis B virus reactivation in patients with nasopharyngeal carcinoma with lamivudine.
    Yeo W; Hui EP; Chan AT; Ho WM; Lam KC; Chan PK; Mok TS; Lee JJ; Mo FK; Johnson PJ
    Am J Clin Oncol; 2005 Aug; 28(4):379-84. PubMed ID: 16062080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
    Schnepf N; Sellier P; Bendenoun M; Zini JM; Sanson-le Pors MJ; Mazeron MC
    J Clin Virol; 2007 May; 39(1):48-50. PubMed ID: 17368969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.
    Yeo W; Steinberg JL; Tam JS; Chan PK; Leung NW; Lam KC; Mok TS; Johnson PJ
    J Med Virol; 1999 Nov; 59(3):263-9. PubMed ID: 10502254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.